Increased activities of phospholipase A(2) and C (PLC) have been obser
ved in the bronchoalveolar lavages of patients with adult respiratory
distress syndrome (ARDS). DL-alpha-Di-O-hexadecylphosphonocholine [(R)
(S)-DEPN-8], a surfactant analog of superior surface activity to the m
ajor lung surfactant phospholipid, dipalmitoylphosphatidylcholine (DPP
C), is not a substrate for phospholipases A(1), A(2) and D, but is a s
ubstrate for PLC. (R)(S)-DEPN-8 was found in vitro to undergo signific
antly less PLC-catalyzed degradation as compared to DPPC. The results
suggest that (R)(S)-DEPN-8 and structurally related analogs may be use
ful as components of exogenous replacement surfactant formulations for
the treatment of ARDS-related lung injuries.